๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Denosumab - Medicines in Ireland

29 authorised products containing Denosumab, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 29 authorised medicines
MedicineActive substanceLicence holderStatus
Bildyos 60 mg solution for injection
EU/1/25/1978/002
Denosumab Sciencepharma Sp. z o.o. โ€”
Bildyos 60 mg solution for injection in pre-filled syringe
EU/1/25/1978/001
Denosumab Sciencepharma Sp. z o.o. โ€”
Bilprevda 120 mg solution for injection
EU/1/25/1979/001
Denosumab Henlius Europe GmbH โ€”
BOMYNTRA 120 mg solution for injection in pre-filled syringe
EU/1/25/1953/04-06
Denosumab Fresenius Kabi Deutschland GmbH โ€”
BOMYNTRA 120 mg solution for injection in vial
EU/1/25/1953/01-03
Denosumab Fresenius Kabi Deutschland GmbH โ€”
Conexxence 60 mg solution for injection in pre-filled syringe
EU/1/25/1954/01
Denosumab Fresenius Kabi Deutschland GmbH โ€”
Denbrayce 120 mg solution for injection
EU/1/25/1936/001
Denosumab Mabxience Research, S.L. โ€”
Enwylma 120 mg solution for injection
EU/1/25/1944/001
Denosumab Zentiva k.s. โ€”
Evfraxy 60 mg solution for injection in pre-filled syringe
EU/1/25/1946/001
Denosumab Biosimilar Collaborations Ireland Limited โ€”
Izamby 60 mg solution for injection in pre-filled syringe
EU/1/25/1935/001
Denosumab Mabxience Research, S.L. โ€”
Jubbonti 60 mg solution for injection in pre-filled syringe
EU/1/24/1813/001
Denosumab Sandoz GmbH โ€”
Jubereq 120 mg solution for injection
EU/1/25/1921/001-003
Denosumab Accord Healthcare S.L.U. โ€”
Junod 60 mg solution for injection in pre-filled syringe
EU/1/25/1933/001
Denosumab Gedeon Richter Plc โ€”
Kefdensis 60 mg solution for injection in pre-filled syringe
EU/1/25/1980/001
Denosumab Stada Arzneimittel AG โ€”
Obodence 60 mg solution for injection in pre-filled syringe
EU/1/24/1890/001
Denosumab Samsung Bioepis NL B.V. โ€”
Osenvelt 120 mg solution for injection
EU/1/24/1904/001-003
Denosumab Celltrion Healthcare Hungary Kft. โ€”
Osvyrti 60mg Solution for injection in pre-filled syringe
EU/1/25/1922/002
Denosumab Accord Healthcare S.L.U. โ€”
Ponlimsi 60 mg solution for injection in pre-filled syringe
EU/1/25/1986/001
Denosumab TEVA GmbH โ€”
Prolia 60 mg solution for injection in pre-filled syringe
EU/1/10/618/1-4
Denosumab Amgen Europe B.V., โ€”
Rolcya 60 mg solution for injection in pre-filled syringe
EU/1/25/1958/001
Denosumab Sandoz GmbH โ€”
Stoboclo 60 mg solution for injection in pre-filled syringe
EU/1/24/1905/001
Denosumab Celltrion Healthcare Hungary Kft. โ€”
Vevzuo 120 mg solution for injection
EU/1/25/1945/001-003
Denosumab Biosimilar Collaborations Ireland Limited โ€”
Vysribli (previously known as Denosumab Intas) 60 mg solution for injection in pre-filled syringe
EU/1/25/1993/001
Denosumab Intas Third Party Sales 2005 S.L. โ€”
Wyost 120 mg solution for injection
EU/1/24/1812/001
Denosumab Sandoz GmbH โ€”
Xbryk 120 mg solution for injection
EU/1/24/1889/001-002
Denosumab Samsung Bioepis NL B.V. โ€”
XGEVA 120 mg solution for injection
EU/1/11/703/001-002
Denosumab Amgen Europe B.V., โ€”
Yaxwer 120 mg solution for injection
EU/1/25/1934/001-003
Denosumab Gedeon Richter Plc โ€”
ZADENVI 60 mg solution for injection in pre-filled syringe
EU/1/25/1937/001
Denosumab Zentiva k.s. โ€”
Zvogra 120 mg solution for injection
EU/1/25/1981/001-003
Denosumab Stada Arzneimittel AG โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.